tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
EGRX is currently covered by 2 analysts with an average price target of $13.82. This is a potential upside of $13.27 (2412.73%) from yesterday's end of day stock price of $0.55.
Eagle Pharmaceuticals's activity chart (see below) currently has 64 price targets and 61 ratings on display. The stock rating distribution of EGRX is 66.67% HOLD and 33.33% SELL.
Analysts average stock forecasts to be materialized ratio is 71.84% with an average time for these price targets to be met of 164.2 days.
Highest price target for EGRX is $26, Lowest price target is $19, average price target is $13.82.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 09-Aug-2023. First documented stock forecast 13-Aug-2014.
Currently out of the existing stock ratings of EGRX, 2 are a HOLD (66.67%), 1 are a SELL (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$17
$15.01 (754.27%)
$31
1 years 4 months 12 days ago
(09-Aug-2023)
10/11 (90.91%)
$-2.23 (-11.60%)
47
Hold
$33
$31.01 (1558.29%)
$50
1 years 9 months 8 days ago
(13-Mar-2023)
4/5 (80%)
$7.49 (29.36%)
33
Buy
2 years 8 months 23 days ago
(28-Mar-2022)
1/2 (50%)
$46.76 (113.39%)
395
Buy
$57
3 years 8 months 14 days ago
(07-Apr-2021)
3/7 (42.86%)
$13.88 (32.19%)
212
Hold
$41
$25.23 (159.99%)
$52
5 years 8 months 29 days ago
(22-Mar-2019)
21/22 (95.45%)
$0.44 (0.83%)
134
What is EGRX (Eagle Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on EGRX (Eagle Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on EGRX (Eagle Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most bullish on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most reserved on EGRX (Eagle Pharmaceuticals)?
